The traumatic segment by wound type is estimated to lead the market growth during the forecast period.

According to a new market research study of “Middle East and Africa Single-Use Negative Pressure Wound Therapy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Wound Type, End User and Country.” The Middle East and Africa single use negative pressure wound therapy market is expected to reach US$ 24.44 million by 2028 from US$ 15.43 million in 2021; it is estimated to grow with a CAGR of 7.9% from 2021 to 2028. The report highlights trends prevailing in the Middle East and Africa single-use negative pressure wound therapy market and the factors driving market along with those that act as hindrances. 

The healthcare sector has undergone rapid transformations over several years, with the growing acceptance of advanced technologies. Technology-enabled care (TEC) solutions are being adopted in emerging economies with an increase in the need for better healthcare facilities. The surge in the aging population, incidence of chronic illnesses, and advancements in pediatric care are the primary factors driving the global healthcare sector. According to the World Bank data, healthcare expenditure accounts for ~9.94% of global GDP every year. Significant investments in R&D by various healthcare companies, governments, and research organizations and the ongoing improvements in reimbursement policies meant for various medical procedures are expected to fuel the growth of the healthcare sector in the coming years.

Moreover, the increasing number of effective regulations by government bodies is likely to result in better and reliable healthcare facilities, ensuring quality care and patient safety, and mitigating fraud and cyber-threats. Such developments in the healthcare sector worldwide are likely to provide significant growth opportunities for market players for advanced wound care devices, such as single-use negative pressure wound therapy devices. Also, single-use negative pressure wound therapy is among emerging technologies used for the management of burn-related wounds. Thus, the rise in burns and related injuries cases is driving the single-use negative pressure wound therapy devices market.

The recent COVID-19 pandemic is causing turbulence to the economies of the Middle East region. A sudden drop in domestic and external demand for goods and products and halted production due to labor shortage are significant impacts observed in the region. The spread of novel coronavirus in the region caused heavy burdens on healthcare professionals and impacted wound management. During the pandemic, conventional NPWT devices for wound management are facing more challenges, owing to the risk of cross-contamination through these devices. Hence, patients in the Middle East prefer disposable devices during the pandemic rather than using conventional NPWT devices. This will lead to the growth of the Middle East & Africa single-use negative pressure wound therapy device market.

The Middle East and Africa single-use negative pressure wound therapy devices market, based on the wound type was segmented into surgical, traumatic, diabetic foot, sports injuries, venous leg ulcers, and others. The Middle East and Africa single-use negative pressure wound therapy devices market, based on the end user was segmented into hospitals, clinics, ambulatory surgical centers, and others. Geographically, the Middle East and Africa single use negative pressure wound therapy market can be sub-segmented into UAE, Saudi Arabia, South Africa and Rest of Middle East and Africa.

Cardinal Health Inc, ConvaTec Group Plc, Carilex Medical, Genadyne Biotechnologies, Inc., Lohmann & Rauscher GmbH & Co. KG, Medela AG, Mölnlycke Health Care AB, PAUL HARTMANN AG, and Smith & Nephew are among the leading companies operating in the Middle East and Africa single-use negative pressure wound therapy market.